Stocks finished mixed again on Thursday in another quiet session. I checked the calendar, because the action feels eerily like a holiday reprieve. Where is everyone?Or maybe like a calm before a storm given threatening data on nascent deflation and a rollover in corporate earnings. I know it’s almost forbidden to say this out loud with sentiment so bubbly — […]
Every month, we review the latest BAML survey of global fund managers. Among the various ways of measuring investor sentiment, this is one of the better ones as the results reflect how managers are allocated in various asset classes. These managers oversee a combined $700b in assets.The data should be viewed mostly from a contrarian perspective; that is, when equities […]
In a repeat of a dynamic that dominated trading early last year, investors piled into stocks Thursday as Russia signed up for another cease-fire deal in Ukraine while negotiations between Greece and the European establishment suddenly became less acrimonious. While no deal has been announced, the bureaucrats have been making noises about agreeing to the outlines of an agreement which, […]
With the holiday season coming up, it’s been a relatively quiet week for the biotech sector with very few pipeline and regulatory updates. However, companies like Sophiris (SPHS – Snapshot Report) and Cyclacel saw their shares plunging on disappointing pipeline updates.Recap of the Week’s Most Important Stories1. Sophiris faced a major pipeline setback following an interim analysis of an ongoing […]
Bianco said he expects the decline in oil to bite into corporate profits next year.”The combination of a strong dollar and a plunge in oil prices—these things are the hallmarks of a profit recession even if the economy is doing fine,” he said. “You can argue this pain is isolated to multinationals and the producers exposed to the industry. … […]
Source: Biogen IdecAs the year begins to come to a close, biotechnology investors are right to wonder what stocks may be worth owning as we head into 2015. We asked three of our Motley Fool analysts to tell us which three biotechnology stocks will be in their stockings this holiday season. Read on to see which three companies they chose.Cheryl […]
Mergers and acquisitions show no signs of slowing down in the biotech sector with a $3.5 billion acquisition agreement being announced. Meanwhile, Biogen (BIIB – Analyst Report) is advancing towards developing a treatment for Alzheimer’s disease.Recap of the Week’s Most Important Stories1. Biogen is set to move its experimental Alzheimer’s disease treatment, BIIB037, into late-stage testing based on promising interim […]
China overtakes Japan to become world’s second largest stock marketPublished time: November 29, 2014 14:21Get short URLReuters/Carlos BarriaTagsBanking, China, Investment, Japan, MarketsThe capitalization of the Chinese stock market increased 33 percent in 2014 reaching $4.48 trillion, which makes the market second only to the US.Japan’s stock market declined 3.2 percent to $4.46 trillion in 2013, according to Bloomberg analysts.The Chinese […]
Koh Gui Qing and Jason Subler of Reuters report, China surprises with interest rate cut to spur growth:
China cut interest rates unexpectedly on Friday, stepping up efforts to support the world’s second-biggest economy as it heads towards its slowest expansion in nearly a quarter of a century.The cut, the first in over two years, came as factory growth has stalled […]
In this Jan. 5, 2014 file photo, people watch a bluefin tuna laid in front of a sushi restaurant near Tsukiji fish market after the year’s celebratory first auction in Tokyo. The researchers at Tokyo University of Marine Science and Technology are fine-tuning a technology to use mackerel surrogates to spawn the bluefin, a process he hopes will enable fisheries […]
